This PLoS Medicine Debate examines the different approaches that can be taken to tackle neglected tropical diseases (NTDs). Some commentators, like Jerry Spiegel and colleagues from the University of British Columbia, feel there has been too much focus on the biomedical mechanisms and drug development for NTDs, at the expense of attention to the social determinants of disease.
The neglected tropical diseases (NTDs), which affect the very poor, pose a major public health problem in the South-East Asia Region of the World Health Organization (WHO). Although more than a dozen NTDs affect the region, over the past five years four of them in particular
By opening up its database of potential malaria drugs, GlaxoSmithKline has blazed a path that other pharmaceutical companies should follow. (Editorial)
REPORTS from Cambodia that malaria is developing resistance to artemisinins have set alarm bells ringing. Artemisinins are the best drugs we have to treat malaria, and until recently there have been no reports of resistance.
Mosquitoes are getting better at evading pest control for long mosquitoes have been resisting pest control. They are only getting better at it. From 1977 to 1997, India spent more than a quarter of its health budget on malaria control. Yet it remains a formidable public health challenge in the country. A Nigeria-based study by scientists at the Liverpool School of Tropical Medicine
Lymphatic filariasis (LF), a neglected parasitic disease, is one of the leading causes of morbidity, social stigma and economic loss in many tropical and sub-tropical countries.
